V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195370 | 20124872 | 1.75 | 48.7 | null | null | 2017-01-28 | CETUXIMAB | 02 | null | CETUXIMAB | 100586502 |
| 20195374 | 20124873 | 1.72 | 105.8 | Palliative (P) | null | 2018-09-30 | Trastuzumab | 02 | N | TRASTUZUMAB | 101656018 |
| 20195382 | 20124874 | 1.59 | 92.2 | Palliative (P) | 2016-06-16 | 2016-06-30 | CETUXIMAB | N | N | CETUXIMAB | 101562939 |
| 20195384 | 20124875 | 1.7 | 96 | Palliative (P) | null | 2019-09-08 | Trastuzumab | 02 | N | TRASTUZUMAB | 101123414 |
| 20195391 | 20124876 | 1.48 | 54.2 | 03 | 2018-03-02 | 2018-03-08 | Capecitabine + Cisplatin + RT | null | Y | CAPECITABINE + CISPLATIN | 100644141 |
| 20195398 | 20124877 | 1.88 | 63.7 | Curative (C) | 2018-12-20 | 2019-01-11 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100748728 |
| 20195403 | 20124878 | 1.58 | 59 | Curative (C) | null | 2018-09-07 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 101437266 |
| 20195406 | 20124879 | 1.65 | 90 | Curative (C) | null | 2019-01-26 | CETUXIMAB | 02 | N | CETUXIMAB | 101189856 |
| 20195408 | 20124880 | null | null | Palliative (P) | null | 2018-08-14 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 101803143 |
| 20195409 | 20124881 | 1.74 | null | Palliative (P) | null | 2017-12-04 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 101234948 |
| 20195418 | 20124882 | 1.68 | 100.6 | null | null | 2016-09-02 | Trastuzumab 21 day maintenance | N | null | TRASTUZUMAB | 101661064 |
| 20195419 | 20124883 | 1.7 | 75 | null | 2018-09-07 | 2018-09-07 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100331157 |
| 20195422 | 20124884 | 1.8 | 75 | Neo-adjuvant (N) | 2018-01-07 | 2018-03-11 | Cetuximab 14 day | null | Y | CETUXIMAB | 100319484 |
| 20195425 | 20124885 | 1.62 | 88 | Neo-adjuvant (N) | 2018-08-02 | 2018-10-21 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100279233 |
| 20195455 | 20124886 | 1.77 | 57 | Palliative (P) | null | 2021-05-08 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100268488 |
| 20195463 | 20124887 | null | 105.8 | null | 2017-12-27 | 2017-12-27 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101284064 |
| 20195465 | 20124888 | 1.8 | 46.6 | Curative (C) | 2017-03-10 | 2017-03-12 | CETUXIMAB | 02 | Y | CETUXIMAB | 100975982 |
| 20195466 | 20124889 | 1.73 | 73 | Neo-adjuvant (N) | null | 2020-03-12 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101694548 |
| 20195475 | 20124890 | 1.75 | 55 | null | null | 2019-06-24 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100383294 |
| 20195476 | 20124891 | 1.77 | 63.1 | Palliative (P) | null | 2017-12-04 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100500654 |
| 20195479 | 20124892 | 1.69 | 58.1 | null | 2019-08-09 | 2019-09-02 | CETUXIMAB | 02 | Y | CETUXIMAB | 100008514 |
| 20195486 | 20124893 | 1.74 | 61.6 | Palliative (P) | 2016-08-14 | 2016-08-14 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101008089 |
| 20195498 | 20124894 | 1.71 | 63.55 | Palliative (P) | 2020-03-31 | 2020-03-31 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100866133 |
| 20195504 | 20124895 | 1.69 | 78.5 | null | 2017-02-18 | 2017-02-18 | CETUXIMAB | 02 | null | CETUXIMAB | 101568889 |
| 20195507 | 20124896 | 1.53 | 55 | Palliative (P) | 2017-05-11 | 2017-05-25 | CETUXIMAB | 02 | N | CETUXIMAB | 100193126 |
| 20195510 | 20124897 | 1.67 | 67.2 | Palliative (P) | 2016-03-03 | 2016-04-07 | Trastuzumab | 02 | N | TRASTUZUMAB | 101161622 |
| 20195515 | 20124898 | 1.69 | 46.6 | Curative (C) | 2016-07-06 | 2016-07-20 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100564187 |
| 20195516 | 20124899 | 0 | 55.3 | Palliative (P) | 2016-12-24 | 2016-12-24 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101743268 |
| 20195520 | 20124900 | 1.7 | null | null | 2017-01-21 | 2017-02-01 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101867162 |
| 20195523 | 20124901 | 1.81 | 107.6 | Palliative (P) | null | 2017-03-28 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101013565 |
| 20195525 | 20124902 | 1.77 | 81.2 | null | 2018-06-27 | 2018-06-27 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100223634 |
| 20195527 | 20124903 | 1.61 | 57 | null | 2018-06-16 | 2018-07-09 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 100391713 |
| 20195531 | 20124904 | null | null | null | 2017-12-08 | 2018-01-17 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100330235 |
| 20195532 | 20124905 | 1.54 | 46.6 | Curative (C) | null | 2018-04-03 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100870356 |
| 20195535 | 20124906 | 1.73 | 74.6 | null | 2016-01-20 | 2016-02-15 | Cetuximab 14 day | null | null | CETUXIMAB | 100606234 |
| 20195540 | 20124907 | 1.52 | 62.8 | Palliative (P) | null | 2016-09-09 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100820482 |
| 20195546 | 20124908 | 1.59 | 68.3 | Curative (C) | null | 2018-03-11 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 101741425 |
| 20195547 | 20124909 | 1.6 | 68 | Curative (C) | null | 2017-04-18 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 101448244 |
| 20195553 | 20124910 | 1.65 | 83.6 | null | 2016-07-16 | 2016-07-30 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 100804314 |
| 20195556 | 20124911 | 1.9 | 124.2 | Curative (C) | 2019-02-08 | 2019-02-26 | CETUXIMAB | 02 | null | TRASTUZUMAB | 101285432 |
| 20195557 | 20124912 | 1.65 | 103.1 | Palliative (P) | 2019-09-01 | 2019-09-06 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100492201 |
| 20195562 | 20124913 | 1.76 | 91.1 | null | 2018-09-03 | 2018-10-20 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100722979 |
| 20195564 | 20124914 | 1.8 | 52.1 | Palliative (P) | 2018-02-16 | 2018-07-21 | CETUXIMAB | 02 | N | CETUXIMAB | 100651874 |
| 20195566 | 20124915 | 1.7 | 85.7 | Neo-adjuvant (N) | 2016-04-04 | 2016-05-04 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100661580 |
| 20195567 | 20124916 | 1.63 | 75.3 | Palliative (P) | 2020-01-07 | 2020-01-13 | Trastuzumab | 02 | N | TRASTUZUMAB | 101682042 |
| 20195570 | 20124917 | 1.73 | 52 | null | 2017-11-17 | 2017-11-17 | Trastuzumab | 02 | N | TRASTUZUMAB | 100683810 |
| 20195572 | 20124918 | 1.72 | 108 | null | 2019-01-31 | 2019-05-18 | CETUXIMAB | 02 | N | CETUXIMAB | 100075171 |
| 20195573 | 20124919 | 1.72 | 82.5 | Curative (C) | 2016-04-09 | 2016-04-14 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101681600 |
| 20195575 | 20124920 | 1.56 | 75 | Curative (C) | 2018-10-09 | 2019-05-04 | CETUXIMAB | 02 | N | CETUXIMAB | 100014831 |
| 20195591 | 20124921 | 1.47 | 57 | Palliative (P) | 2017-02-05 | 2017-03-01 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100544120 |